Autret A, et al.: Human sleep and 5-HTP. Effects of repeated high doses and of association with benserazide. Electroencephalogr Clin Neurophysiol 1976; 41:408-13.
Blundel JE and Leshem MB: The effect of 5-HTP on food intake and on the anorexic action of amphetamine and fenfluramine. J Pharm Pharmacol 1975;27:31-7.
Bono G, et al.: Serotonin precursors in migraine prophylaxis. Adv Neurol 1982; 33:357-63.
Byerley WF, Judd LL, Reimherr FW, Grosser BI. 5-hydroxytryptophan: A review of its antidepressant efficacy and adverse effects. J Clin Psychopharmacol 1987;7:127-37.
Cangiano C, et al.: Effects of 5-hydroxytryptophan on eating behavior and adherence to dietary prescriptions in obese adult subjects. Adv Exp Med Biol 1991;294:591-3.
Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr. 1992; 56:863?867.
Cangiano C, Laviano A, Del Ben M, et al. Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients. Int J Obes Relat Metab Disord 1998; 22:648-54.
Caruso I, et al.: Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 1990; 18:201-9.
Ceci F, Cangiano C, Cairella M, et al. The effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjects. J Neural Transm 1989;76(2):109-17.
De Benedittis G, Massei R. 5-HT precursors in migraine prophylaxis: a double-blind cross-over study with L-5-hydroxytryptophan versus placebo. Clin J Pain 1986;3:123-9.
De Giorgis G, Miletto R, Iannuccelli M, et al. Headache in association with sleep disorders in children: a psychodiagnostic evaluation and controlled clinical study - L-5-HTP versus placebo. Drugs Exptl Clin Res 1987; 13(7):425-33.
Guilleminault C, Cathala HP and Castaigne P: Effects of 5-HTP on sleep of a patient with brain stem lesion. Electroencephalog Clin Neurophysiol 1973;34:177-84.
Kielholz P: Treatment for therapy-resistant depression. Psychopathology 1986. 19 (Suppl. 2):194-200.
Lam RW, Levitan RD, Tam EM, et al. L-Tryptophan. Augmentation Of Light Therapy In Patients With Seasonal Affective Disorder. Can J Psychiatry 1997;42:303?306.
Maissen CP, Ludin HP. Comparison of the effect of 5-hydroxytryptophan and propranolol in the interval treatment of migraine. Schweizerische Medizinische Wochenschrift /Journal Suisse de Medecine 1991; 121:1585-90 (text in in German).
Mathew NT. 5-hydroxytryptophan in the prophylaxis of migraine. Headache 1978;18:111-3.
Nicolodi M and Sicuteri F: Fibromyalgia and migraine, two faces of the same mechanism. Serotonin as the common clue for pathogenesis and therapy. Adv Exp Med Biol 1996; 398:373-9.
Poldinger W, Calanchini B, Schwarz W. A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine. Psychopathology 1991; 24(2):53-81.
Puttini PS and Caruso I: Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study. J Int Med Res 1992; 20:182-9.
Ribeiro CA. L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society. Headache 2000; 40:451-6.
Santucci M, et al.: L-5-hydroxytryptophan versus placebo in childhood migraine prophylaxis: A double-blind crossover study. Cephalgia 1986; 6:155-7.
Soulairac A and Lambinet H: Clinical studies of the effect of the serotonin precursor, L-5-hydroxytryptophan, on sleep disorders. Schweiz Rundsch Med Prax 1988; 77:19-23.
Titus F, Davalos A, Alom J, Codina A. 5-hydroxytryptophan versus methysergide in the prophylaxis of migraine. Eur Neurol 1986; 25:327-9.
van Hiele JJ: L-5-hydroxytryptophan in depression: The first substitution therapy in psychiatry? Neuropsychobiology 1980; 6:230-40.
Wurtman RJ and Wurtman JJ: Brain serotonin, carbohydrate-craving, obesity and depression. Adv Exp Med Biol 1996; 398:35-41.
Zmilacher K, Battegay R, Gastpar M. L-5-hydroxytryptophan alone and in combination with a peripheral decarboxylase inhibitor in the treatment of depression. Neuropsychobiology 1988; 20:28-35.
Se også "Aminosyrer, kilder til" her
